Alfonso Zulueta
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Alfonso G.
Zulueta is Chief Executive Officer & Owner at Cz Ventures LLC, Non-Executive Chairman at Interpharma Investments Ltd., Independent Director at CTS Corp.
since 2018, Director at The American Chamber of Commerce in Japan, Director at Glooko, Inc. since 2022, and Independent Director at Lupin Ltd. since 2024.
Former roles include Chairman at Pharmaceutical Research & Manufacturers of America from 2012 to 2013, Independent Director at Amarin Corp.
Plc from 2022 to 2023, Director at The U.S.-Japan Business Council, Inc., Director at European Federation of Pharmaceutical Industries & Assns, Independent Director at Syneos Health, Inc. from 2022 to 2023, Director at Calidi Biotherapeutics, Inc., Director at Calidi Biotherapeutics (Nevada), Inc., Senior VP & President-Lilly International at Eli Lilly & Co. from 2017 to 2021, and President & General Manager at Eli Lilly Japan KK.
Education includes an undergraduate degree from De La Salle University in 1983 and an MBA from the University of Virginia Darden School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CTS CORPORATION 0,08 % | 20/03/2026 | 22 213 ( 0,08 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CTS CORPORATION | Directeur/Membre du Conseil | 02/04/2018 |
| LUPIN LIMITED | Directeur/Membre du Conseil | 06/05/2024 |
Interpharma Investments Ltd.
Interpharma Investments Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in the distribution and manufacturing of pharmaceutical products | Président | - |
Glooko, Inc.
Glooko, Inc. Packaged SoftwareTechnology Services Provides remote patient monitoring and digital health solutions for diabetes | Directeur/Membre du Conseil | 27/04/2022 |
The American Chamber of Commerce in Japan
The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/11/2023 |
| SYNEOS HEALTH, INC. | Directeur/Membre du Conseil | 28/09/2023 |
| AMARIN CORPORATION PLC | Directeur/Membre du Conseil | 06/03/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 26/12/2021 |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
CTS Corp.
CTS Corp. Electronic Production EquipmentElectronic Technology Designs, manufactures and sells sensors, connectivity components and actuators to the transportation, industrial and medical markets | Electronic Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Lupin Ltd.
Lupin Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and distributes pharmaceutical ingredients and formulations | Health Technology |
De La Salle University
De La Salle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
The U.S.-Japan Business Council, Inc.
The U.S.-Japan Business Council, Inc. The U.S.-Japan Business Council, Inc. is comprised of more than 65 leading U.S.-headquartered companies that prioritize doing business in Japan and is the primary U.S.-based business organization promoting stronger economic relations between the two countries. The private company is based in Washington, DC. The USJBC's core mission is to advance business interests, identify and expand new opportunities, and facilitate growth across sectors including the digital economy, energy and infrastructure, financial services, healthcare innovation, travel, tourism, and transportation. | |
The American Chamber of Commerce in Japan
The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Health Technology |
Interpharma Investments Ltd.
Interpharma Investments Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in the distribution and manufacturing of pharmaceutical products | Health Technology |
Glooko, Inc.
Glooko, Inc. Packaged SoftwareTechnology Services Provides remote patient monitoring and digital health solutions for diabetes | Technology Services |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national